NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Comparison of the ID NOW and Accula Point-of-Care Assays for Detection of COVID-19

WithdrawnN/A

Sponsor: Henry Ford Health System

Conditions: Covid-19

Interventions: ID NOW vs. Accula

Countries: United States

This study is a comparison of the ID Now COVID-19 (Abbott) assay to the Accula SARS-CoV-2 (Mesa Biotech) assay to assist in the identification of infection with COVID-19. The tests will be compared for sensitivity, specificity, positive predictive value and negative predictive value.

Eligibility overview

Sex: ALL

Age: 18 Years to 95 Years

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Covid-19 testing has been ordered in the Emergency Dept. or for inpatients in the hospital or patient has already tested positive via PCR.
* Adult patients
* Consent obtained

Exclusion Criteria:

* Testing not ordered or tested negative via PCR.
* Children
* Do not consent

Locations (1)

Detroit, Michigan, United States